113 related articles for article (PubMed ID: 23179147)
1. Smad3 and Smad3 phosphoisoforms are prognostic markers of gastric carcinoma.
Kim SH; Kim KH; Ahn S; Hyeon J; Park CK
Dig Dis Sci; 2013 Apr; 58(4):989-97. PubMed ID: 23179147
[TBL] [Abstract][Full Text] [Related]
2. Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy.
Kim SH; Ahn S; Park CK
Hepatobiliary Pancreat Dis Int; 2012 Feb; 11(1):51-9. PubMed ID: 22251470
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of Smad3, Smad4, Smad3 phosphoisoform expression in esophageal squamous cell carcinoma.
Cho SY; Ha SY; Huang SM; Kim JH; Kang MS; Yoo HY; Kim HH; Park CK; Um SH; Kim KH; Kim SH
Med Oncol; 2014 Nov; 31(11):236. PubMed ID: 25267569
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Smad3 phosphoisoforms in cyst-lining epithelial cells in the
Hama T; Nakanishi K; Sato M; Mukaiyama H; Togawa H; Shima Y; Miyajima M; Nozu K; Nagao S; Takahashi H; Sako M; Iijima K; Yoshikawa N; Suzuki H
Am J Physiol Renal Physiol; 2017 Dec; 313(6):F1223-F1231. PubMed ID: 28877884
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis.
Kawamata S; Matsuzaki K; Murata M; Seki T; Matsuoka K; Iwao Y; Hibi T; Okazaki K
Inflamm Bowel Dis; 2011 Mar; 17(3):683-95. PubMed ID: 20602465
[TBL] [Abstract][Full Text] [Related]
6. Smad3 phosphoisoform-mediated signaling during sporadic human colorectal carcinogenesis.
Matsuzaki K
Histol Histopathol; 2006 Jun; 21(6):645-62. PubMed ID: 16528675
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
[TBL] [Abstract][Full Text] [Related]
8. Role of phosphorylated Smad3 signal components in intraductal papillary mucinous neoplasm of pancreas.
Hori Y; Ikeura T; Yamaguchi T; Yoshida K; Matsuzaki K; Ishida M; Satoi S; Okazaki K
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):581-589. PubMed ID: 32532597
[TBL] [Abstract][Full Text] [Related]
9. Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells.
Li Q; Liu G; Yuan H; Wang J; Guo Y; Chen T; Zhai R; Shao D; Ni W; Tai G
Oncotarget; 2015 Feb; 6(6):4253-65. PubMed ID: 25714018
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
Matsuzaki K; Murata M; Yoshida K; Sekimoto G; Uemura Y; Sakaida N; Kaibori M; Kamiyama Y; Nishizawa M; Fujisawa J; Okazaki K; Seki T
Hepatology; 2007 Jul; 46(1):48-57. PubMed ID: 17596875
[TBL] [Abstract][Full Text] [Related]
11. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation.
Wu C; Chen W; Fang M; Boye A; Tao X; Xu Y; Hou S; Yang Y
J Ethnopharmacol; 2019 Mar; 231():98-112. PubMed ID: 30412748
[TBL] [Abstract][Full Text] [Related]
12. Smad3 C-terminal phosphorylation site mutation attenuates the hepatoprotective effect of salvianolic acid B against hepatocarcinogenesis.
Gong Y; Li D; Li L; Yang J; Ding H; Zhang C; Wen G; Wu C; Fang Z; Hou S; Yang Y
Food Chem Toxicol; 2021 Jan; 147():111912. PubMed ID: 33290806
[TBL] [Abstract][Full Text] [Related]
13. IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling.
Liu R; Tang C; Shen A; Luo H; Wei X; Zheng D; Sun C; Li Z; Zhu D; Li T; Wu Z
Oncotarget; 2016 Dec; 7(51):85079-85096. PubMed ID: 27835881
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta during carcinogenesis: the shift from epithelial to mesenchymal signaling.
Matsuzaki K; Okazaki K
J Gastroenterol; 2006 Apr; 41(4):295-303. PubMed ID: 16741607
[TBL] [Abstract][Full Text] [Related]
15. TGFβ1-Smad3-Jagged1-Notch1-Slug signaling pathway takes part in tumorigenesis and progress of tongue squamous cell carcinoma.
Zhang T; Liang L; Liu X; Wu JN; Chen J; Su K; Zheng Q; Huang H; Liao GQ
J Oral Pathol Med; 2016 Aug; 45(7):486-93. PubMed ID: 26764364
[TBL] [Abstract][Full Text] [Related]
16. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
17. Smad Phospho-Isoforms for Hepatocellular Carcinoma Risk Assessment in Patients with Nonalcoholic Steatohepatitis.
Suwa K; Yamaguchi T; Yoshida K; Murata M; Ichimura M; Tsuneyama K; Seki T; Okazaki K
Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31991602
[TBL] [Abstract][Full Text] [Related]
18. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
[TBL] [Abstract][Full Text] [Related]
19. Deregulated E2F5/p38/SMAD3 Circuitry Reinforces the Pro-Tumorigenic Switch of TGFβ Signaling in Prostate Cancer.
Majumder S; Bhowal A; Basu S; Mukherjee P; Chatterji U; Sengupta S
J Cell Physiol; 2016 Nov; 231(11):2482-92. PubMed ID: 26919443
[TBL] [Abstract][Full Text] [Related]
20. Nuclear expression of Smad proteins and its prognostic significance in clear cell renal cell carcinoma.
Park JH; Lee C; Suh JH; Chae JY; Moon KC
Hum Pathol; 2013 Oct; 44(10):2047-54. PubMed ID: 23668999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
